What are the symptoms of scleroderma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Scleroderma (Systemic Sclerosis)

Scleroderma presents with a characteristic constellation of vascular, skin, and internal organ manifestations, with Raynaud phenomenon and skin thickening being the hallmark features that nearly all patients experience. 1, 2

Core Vascular Manifestations

  • Raynaud phenomenon occurs in nearly all patients (>95%) and is often the earliest presenting symptom 1, 2
  • Digital ulcers affect approximately 50% of patients and represent significant vascular compromise 1, 2

Skin Manifestations

  • Skin thickening (scleroderma) is the defining feature, with hardening and tightening of the skin that can be measured using the modified Rodnan skin score (0-51 scale) 1, 2
  • Puffy fingers may occur early in the disease course, particularly in prescleroderma presentations 1
  • In diffuse cutaneous SSc, skin thickening typically progresses over the first 4 years before potentially regressing 1
  • The extent of skin involvement determines disease classification: limited disease affects areas distal to elbows/knees, while diffuse disease extends proximally to trunk 1, 2

Pulmonary Symptoms

  • Nonproductive cough of varying severity is a frequent symptom, particularly in patients with interstitial lung disease (ILD) or aspiration from esophageal involvement 3
  • Dyspnea develops as pulmonary complications progress 3
  • Respiratory involvement occurs in up to 85% of patients, with ILD affecting 40-75% based on lung function changes 3, 1
  • Patients with scleroderma-associated ILD demonstrate increased sensitivity of the cough reflex compared to those without ILD 3

Gastrointestinal Symptoms

  • Gastrointestinal involvement affects nearly 90% of patients, with the esophagus being most commonly affected 1, 2
  • Gastroesophageal reflux disease is common due to esophageal dysmotility 4
  • Small bowel, colon, and anorectal involvement can occur sequentially 1
  • Malnutrition is the leading cause of mortality attributed to GI tract involvement 1
  • Aspiration can occur due to esophageal dysfunction 3

Musculoskeletal Symptoms

  • Inflammatory arthritis occurs in approximately 15% of patients 1
  • Myositis or myopathy affects about 15% of patients 1
  • Tendon friction rubs may be present and indicate more aggressive disease 1

Renal Manifestations

  • Scleroderma renal crisis (SRC) occurs predominantly in early diffuse cutaneous SSc, particularly in patients with anti-RNA polymerase III antibodies 1
  • Risk factors include male sex, tendon friction rubs, rapidly progressive skin involvement, and glucocorticoid use 1

Cardiac Symptoms

  • Arrhythmias and heart failure may develop with cardiac involvement 1
  • Cardiomyopathy can occur as a disease manifestation 3

Additional Systemic Symptoms

  • Sicca symptoms (dry eyes and mouth) can occur, particularly when overlapping with Sjögren syndrome 3
  • Calcinosis (calcium deposits in tissues) may develop 3
  • Pulmonary arterial hypertension risk increases with longer disease duration, older age, and low diffusing capacity 1

Important Clinical Pearls

The absence of Raynaud phenomenon, specific capillaroscopic abnormalities, or scleroderma-specific autoantibodies should prompt consideration of scleroderma mimics rather than true systemic sclerosis 5. The typical patient is a young or middle-aged woman with a history of Raynaud phenomenon who presents with skin induration and internal organ dysfunction 4. Approximately 80% of patients are female, with half presenting before age 40 6.

References

Guideline

Systemic Sclerosis Clinical Manifestations and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Systemic Sclerosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of scleroderma.

Acta medica Indonesiana, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.